Steward Partners Investment Advisory, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $8.95 Billion
- Q1 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 305 shares of ARWR stock, worth $7,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305
Previous 205
48.78%
Holding current value
$7,646
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$311 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$214 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$164 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$104 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.65B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...